Changes in trabecular bone score and bone mineral density in Chinese HIV-Infected individuals after one year of antiretroviral therapy

Changes in trabecular bone score and bone mineral density in Chinese HIV-Infected individuals after one year of antiretroviral therapy

Objective: Human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) have been associated with reduced bone mineral density (BMD) in persons with HIV (PWH). BMD provides information only about bone mineral quantity. Trabecular bone score (TBS) is a noninvasive tool that estimates...

Full description

Bibliographic Details
Main Authors:	Wen-Min Guan, Wei Pan, Wei Yu, Wei Cao, Qiang Lin, Zai-Zhu Zhang, Xiao-Jing Song, Yan-Ling Li, Jun-Ping Tian, Ying Xu, Tai-Sheng Li, Evelyn Hsieh
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	Journal of Orthopaedic Translation
Subjects:	Human immunodeficiency virus (HIV) Antiretroviral therapy (ART) Bone mineral density (BMD) Trabecular bone score (TBS) Tenofovir disoproxil fumarate (TDF)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214031X21000243

Similar Items

Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health
by: Yasser El Miedany, et al.
Published: (2024-03-01)

Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients
by: Barbara Ruaro, et al.
Published: (2020-09-01)

What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases?
by: Barbara Ruaro, et al.
Published: (2020-11-01)

Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study
by: Mahoko Ikeda, et al.
Published: (2021-05-01)

Decreased Trabecular Bone Score in Patients With Active Endogenous Cushing’s Syndrome
by: Barbara Stachowska, et al.
Published: (2021-01-01)

Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate
by: Kate Braithwaite, et al.
Published: (2021-08-01)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
by: Jeffrey Kim, et al.
Published: (2023-03-01)

Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort
by: Bernard Surial, et al.
Published: (2019-10-01)

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
by: Hung-Yao Lin, et al.
Published: (2022-04-01)

Vitamin D and Calcium Supplementation Reverses Tenofovir-Caused Bone Mineral Density Loss in People Taking ART or PrEP: A Systematic Review and Meta-Analysis
by: Xiaoyan Bi, et al.
Published: (2022-03-01)

Utilidad del trabecular bone score en sujetos adultos con osteogénesis imperfecta
by: Florez H, et al.
Published: (2022-11-01)

Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
by: Fa- Da Wang, et al.
Published: (2023-09-01)

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate in a cohort of patients with HBV infection: A retrospective study
by: Giacomo Stroffolini, et al.
Published: (2024-02-01)

Efficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China
by: Ya-Song Wu, et al.
Published: (2016-01-01)

Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients
by: Antonino Catalano, et al.
Published: (2022-09-01)

The Bone Strain Index: An Innovative Dual X-ray Absorptiometry Bone Strength Index and Its Helpfulness in Clinical Medicine
by: Fabio Massimo Ulivieri, et al.
Published: (2022-04-01)

Lipid profile after switching from TDF (tenofovir disoproxil)-containing to TAF (tenofovir alafenamide)-containing regimen in virologically suppressed people living with HIV
by: Michał Łomiak, et al.
Published: (2023-09-01)

The Effects of Antivirals for Human Immunodeficiency Virus Treatment on Renal Functions
by: Mehmet ÇABALAK, et al.
Published: (2022-05-01)

Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes
by: Ah Ram Lee, et al.
Published: (2021-02-01)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
by: Tingyan Wang, et al.
Published: (2021-06-01)

Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity
by: Rossella Tozzi, et al.
Published: (2022-02-01)

Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey
by: Sabrina Paolino, et al.
Published: (2021-09-01)

Chronic Kidney Disease in a Large National Human Immunodeficiency Virus Treatment Program
by: Ninutcha Paengsai, et al.
Published: (2022-08-01)

Comparative application of derivative spectrophotometric and HPLC techniques for the simultaneous determination of lamivudine and tenofovir disoproxil fumarate in fixed-dose combined drugs
by: Edebi N. Vaikosen, et al.
Published: (2023-03-01)

Renal Dysfunction and Tubulopathy Induced by High-Dose Tenofovir Disoproxil Fumarate in C57BL/6 Mice
by: Eungyeong Jang, et al.
Published: (2020-10-01)

Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study
by: Samadhi Patamatamkul, et al.
Published: (2022-12-01)

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
by: Pei-Yuan Su, et al.
Published: (2021-11-01)

Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly
by: Aleksandra Jawiarczyk-Przybyłowska, et al.
Published: (2022-04-01)

A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women
by: Alireza Mirzaei, et al.
Published: (2018-06-01)

Renal function and lipid metabolism in Japanese HIV-1-positive individuals 288 weeks after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate: a single-center, retrospective cohort study
by: Kensuke Abe, et al.
Published: (2024-02-01)

Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial
by: Jun Chen, et al.
Published: (2020-01-01)

The Relationship between Bone Health Parameters, Vitamin D and Iron Status, and Dietary Calcium Intake in Young Males
by: Jadwiga Malczewska-Lenczowska, et al.
Published: (2024-01-01)

Trabecular Bone Score (TBS) in Individuals with Type 2 Diabetes Mellitus: An Updated Review
by: Alexandra-Ioana Trandafir, et al.
Published: (2023-11-01)

Utility and validation of bone mineral density measurements at forearm in predicting trabecular microarchitecture and central‐site osteoporosis in aging Indian postmenopausal women—a promising surrogate?
by: Krishna Prabha Gautam, et al.
Published: (2022-03-01)

Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
by: Tomoya Sano, et al.
Published: (2021-03-01)

Pharmacokinetic Feasibility of Stability-Enhanced Solid-State (SESS) Tenofovir Disoproxil Free Base Crystal
by: Byoung Hoon You, et al.
Published: (2023-05-01)

Observation of Glomerular Filtration Change in Chronic Hepatitis B Patients Using Tenofovir Disoproxil Fumarate
by: Meltem Karslıoğlu
Published: (2024-01-01)

A review of Tenofovir Disoproxil Fumarate associated nephrotoxicity among People Living with HIV: Burden, risk factors and solutions
by: Edwin Sam Asirvatham, et al.
Published: (2024-01-01)

The genotoxicity of Tenofovir disoproxil fumarate in HBV-infected patients
by: Selcen Korkmaz, et al.
Published: (2018-09-01)

Evaluation of genotoxic activity of tenofovir disoproxil fumarate in human peripheral lymphocytes
by: Kubra Kurt, et al.
Published: (2016-06-01)